Editor-in-Chief
Assistant Professor
Department of Nutrition, Health and oncology
Moulay Ismail University
Morocco
Editor-in-Chief
Associate Professor
Department of Genetics and Bioengineering
Yeditepe University
Turkey
Editor-in-Chief
Director-cum-Principal
Pharmacy
Amity University Madhya Pradesh, Gwalior, India
India
Editor-Member
Principal Investigator
Gastroenterology and Liver Diseases
Shahid Beheshti University of Medical Sciences
Iran
Editor-Member
Research Collaborator
Immunology Research Center
Iran University of Medical Sciences
Iran
Editor-Member
Postdoctoral Scientist
Cancer Immunotherapy
University of California, Irvine
United States of America
Editor-Member
Assistant Professor
Cancer Immunotherapy
Fujian Medical University
China
Editor-Member
Postdoctoral Researcher
Department of Medical Life Sciences and Technology
Technical University of Munich
Germany
The Journal of Targeted Oncology Research (JTOR) is an open-access journal dedicated to publishing cutting-edge research in oncology and targeted cancer therapies. The journal aims to promote the global exchange of knowledge and foster collaboration among researchers, clinicians, and healthcare professionals working to advance cancer diagnosis, treatment, and precision medicine.
JTOR serves as a comprehensive platform for disseminating innovative findings in cancer biology, molecular oncology, and translational research. It is committed to improving outcomes for cancer patients by highlighting advancements in targeted therapies, immunotherapies, and precision-based approaches.
The scope of JTOR encompasses all aspects of oncological research, with a particular focus on:
JTOR covers a broad spectrum of cancer types, including but not limited to breast, lung, gastrointestinal, genitourinary, hematological, and pediatric cancers. It also explores emerging areas such as cancer genomics, epigenetics, systems biology, and artificial intelligence in oncology.
By fostering interdisciplinary collaboration and providing a trusted global platform for scientific exchange, JTOR seeks to accelerate the translation of laboratory discoveries into effective clinical applications. The journal upholds a rigorous peer-review process to ensure the publication of high-quality, impactful research that drives progress in oncology and enhances patient outcomes.
With a mission to support evidence-based practice and promote innovation in cancer treatment, the Journal of Targeted Oncology Research (JTOR) aspires to be a leading international resource for oncologists, researchers, and industry professionals working toward a future where cancer is more effectively managed and ultimately, cured.
Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editorialoffice@confseries.net
Rapid Publication Service
Confseries Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Confseries is an open-access platform that publishes thousands of manuscripts from internationally renowned researchers. Every submission is evaluated by our peer reviewers for suitability, and a full description of the peer review process appears below.
At Confseries, peer review is a vital part of our publishing process, ensuring that every manuscript undergoes a rigorous and unbiased evaluation.Each submission is carefully examined by subject experts who provide constructive feedback on improvements or confirm whether the work is ready for publication. To guarantee fairness and thoroughness, manuscripts are assigned to multiple reviewers, each offering their own independent assessment. The review is conducted under a double-blind system, maintaining confidentiality for both authors and reviewers.
Authors are expected to revise their manuscripts in line with reviewer suggestions and then resubmit them for further evaluation. On resubmission, the paper is reviewed again-sometimes by the original reviewers, and at other times by new ones. This review-and-revision cycle continues until the editorial board is fully satisfied that the manuscript meets the standards required for publication.
Confseries places the highest emphasis on research integrity and quality. Our peer review process is collaborative and iterative, reflecting a shared commitment between authors, reviewers, and editorial board members to uphold excellence in scholarly publishing.
